Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sarepta Therapeutics Inc (NASDAQ:SRPT)

14.19
Delayed Data
As of Apr 29
 +0.39 / +2.83%
Today’s Change
8.00
Today|||52-Week Range
41.97
-63.22%
Year-to-Date

Today’s Trading

Previous close13.80
Today’s open13.77
Day’s range13.70 - 15.13
Volume10,368,697
Average volume (3 months)3,771,641
Market cap$630.2M
Dividend yield--
Data as of 3:59pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-53.39%
Earnings growth (this year)+16.15%
Earnings growth (next 5 years)+0.37%
Revenue growth (last year)-87.16%
P/E ratioNM
Price/Sales1,302.11
Price/Book3.31

Competitors

 Today’s
change
Today’s
% change
EPZMEpizyme Inc-0.64-5.79%
PDLIPDL BioPharma Inc+0.01+0.27%
MNKDMannkind Corp-0.09-6.25%
EGRXEagle Pharmaceutical...-1.39-3.54%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 5, 2016
EPS forecast (this quarter)-$1.28
Annual revenue (last year)$1.3M
Annual profit (last year)-$220.0M
Net profit margin-17,560.26%

Profile

Sector
Health Technology
Industry
Biotechnology
Senior VP, Chief Executive &
Medical Officer
Edward M. Kaye
Head-Operations &
Vice President
Gavin T. Malenfant
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs